Monitoring breathing rate at home allows early identification of COPD exacerbations

Chest

Volumn 142, Issue 6, 2012, Pages 1524-1529

  Yañez, Aina M ^a   Guerrero, Dolores ^a   Pérez De Alejo, Rigoberto ^b   Garcia Rio, Francisco ^c   Alvarez Sala, Jose Luis ^d   Calle Rubio, Miriam ^d   Malo De Molina, Rosa ^e   Valle Falcones, Manuel ^e   Ussetti, Piedad ^e   Sauleda, Jaume ^a   Zamora García, Enrique ^f   Rodríguez González Moro, Jose Miguel ^g   Franco Gay, Mercedes ^b   Torrent, Maties ^h   Agustí, Alvar ⁱ  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b Airproducts Sud Europa   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^h IB SALUT   (Spain)

ⁱ UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREATHING RATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; EARLY DIAGNOSIS; EXACERBATION OF COPD; FEMALE; FOLLOW UP; HOME MONITORING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE AIRWAY DISEASE; OXYGEN THERAPY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84870618689     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2728     Document Type: Article

References (18)

1. Buist AS, McBurnie MA, Vollmer WM, et al BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study):. population-based prevalence study. Lancet. 2007;370(9589):741-750. (Pubitemid 47321907)
2. Rodriguez-Roisin R. Toward. consensus definition for COPD exacerbations. Chest. 2000;117(5 suppl 2):398S-401S. (Pubitemid 30314474)
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. Respir Crit Care Med. 2001;163(5):1256-1276. (Pubitemid 32378468)
4. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786-796. (Pubitemid 47320802)
5. Agustí AG, Carrera M, Barbé F, Muñoz A, Togores B. Oxygen therapy during exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 1999;14(4):934-939. (Pubitemid 29519361)
6. Carrera M, Marín JM, Antón A, et al.. controlled trial of noninvasive ventilation for chronic obstructive pulmonary disease exacerbations.. Crit Care. 2009;24(3):473.e7-14.
7. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am. Respir Crit Care Med. 2000;161(5):1608-1613. (Pubitemid 30329036)
8. Chang CL, Sullivan GD, Karalus NC, Mills GD, McLachlan JD, Hancox RJ. Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score. Respirology. 2011;16(1):146-151.
9. de la Iglesia F, Valiño P, Pita S, et al. Factors predicting. hospital stay of over. days in patients with acute exacerbation of chronic obstructive pulmonary disease. Intern Med. 2002;251(6):500-507. (Pubitemid 34537311)
10. Franciosi LG, Page CP, Celli BR, et al. Markers of exacerbation severity in chronic obstructive pulmonary disease. Respir Res. 2006;7:74.
11. Calverley P, Pauwels Dagger R, Löfdahl CG, et al. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J. 2005;26(3):406-413. (Pubitemid 41264201)
12. Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am. Respir Crit Care Med. 2004;169(12):1298-1303. (Pubitemid 39571857)
13. Rabe KF, Hurd S, Anzueto A, et al Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. Respir Crit Care Med. 2007;176(6):532-555. (Pubitemid 47403272)
14. Hurst JR, Vestbo J, Anzueto A, et al Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. Engl. Med. 2010;363(12):1128-1138.
15. Pérez de Alejo R, Esteban R, Sacristán JC, Peces-Barba G. Monitor de cumplimiento de oxigenoterapia domiciliaria Visionox. Evaluación de eficacia. fiabilidad [abstract]. Arch Bronconeumol. 2009;45(especial congreso):97.
16. Tryon WW. simplified time-series analysis for evaluating treatment interventions. Appl Behav Anal. 1982;15(3):423-429.
17. Balleza M, Calaf N, Feixas T, et al. Measuring breathing pattern in patients with chronic obstructive pulmonary disease by electrical impedance tomography [in Spanish]. Arch Bronconeumol. 2009;45(7):320-324.
18. Cantineau JP, Escourrou P, Sartene R, Gaultier C, Goldman M. Accuracy of respiratory inductive plethysmography during wakefulness and sleep in patients with obstructive sleep apnea. Chest. 1992;102(4):1145-1151.